FMP

FMP

Enter

PRPH - ProPhase Labs, ...

photo-url-https://images.financialmodelingprep.com/symbol/PRPH.png

ProPhase Labs, Inc.

PRPH

NASDAQ

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

0.611 USD

-0.0426 (-6.98%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Mr. Ted William Karkus

sector

Healthcare

industry

Drug Manufacturers - Specialty & Generic

exchange

NASDAQ

Description

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab metho...

CIK

0000868278

ISIN

US74345W1080

CUSIP

74345W108

Address

711 Stewart Avenue

Phone

215 345 0919

Country

US

Employee

113

IPO Date

Apr 4, 1994

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

PRPH Financial Summary

CIK

0000868278

Exchange

NASDAQ

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

74345W108

ISIN

US74345W1080

Country

US

Price

0.61

Beta

-0.1

Volume Avg.

171.22k

Market Cap

14.58M

Shares

-

52-Week

0.6105-7.48

DCF

10.92

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.4

P/B

-

Website

https://www.prophaselabs.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest PRPH News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep